A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)
Completed
AstraZeneca
Phase 3
2002-08-01
The purpose of this trial is to see if rosuvastatin will be effective in decreasing the
thickness of the walls of the arteries in the neck for people who already have some evidence
of thickening of these walls.
Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?
Unknown status
Purdue University
Phase 4
2006-02-01
The purpose of this study is to determine whether the effects of rosuvastatin treatment and
exercise training can be synergistic, with respect to the innate immune receptor TLR4,
markers of systemic inflammation, and stimulated production of inflammatory cytokines, in
hypercholesterolemic subjects. It is hypothesized that a rosuvastatin and exercise
intervention will synergistically lower measured variables, so as to be anti-inflammatory.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
